Gentian Violet 1% Solution in the Treatment of Wounds in the Geriatric Patient: A Retrospective Study

Geriatric Nursing

Volumn 32, Issue 2, 2011, Pages 85-95

  Farid, Karen J ^a   Kelly, Kathy ^a   Roshin, Shyla ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL VIOLET;

AGED; ARTICLE; FEMALE; HUMAN; INJURY; MALE; RETROSPECTIVE STUDY; SOLUTION AND SOLUBILITY;

AGED; FEMALE; GENTIAN VIOLET; HUMANS; MALE; RETROSPECTIVE STUDIES; SOLUTIONS; WOUNDS AND INJURIES;

EID: 79953208559     PISSN: 01974572     EISSN: 15283984     Source Type: Journal    
DOI: 10.1016/j.gerinurse.2010.11.001     Document Type: Article

References (43)

1. Agency for Healthcare Research and Quality. Treatment of pressure ulcers treatment of pressure ulcers. Clinical Guideline No. 15 (AHCPR Publication No. 95-0652), December 1994. Available at www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat2.chapter.5124. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat2.chapter.5124.
2. Farid K. Applying observations from forensic science to the understanding of the development of pressure ulcers. Ostomy Wound Manage 2007, 53:26-44.
3. Bauer J., Phillips L.G. MOC PSSM CME article: pressure sores. Plast Reconstr Surg 2008, 121(suppl 1):1-10.
4. Cheung C. Older adults and ulcers: chronic wounds in the geriatric population. Adv Skin Wound Care 2010, 23:39-44.
5. Reddy M. Skin and wound care: important considerations in the older adult. Adv Skin Wound Care 2008, 21:424-436.
6. Woo K.Y., Sibbald R.G. Local wound care for malignant and palliative wounds. Adv Skin Wound Care 2010, 23:417-430.
7. Bhatnagar V., Sundaram K.R. Studies on antibacterial properties of gentian violet impregnated silastic discs. Indian J Med Res 1993, 97:206-208.
8. Phillips S.J. Physiology of wound healing and surgical wound care. ASAIO J 2000, 46:S2-S5.
9. Kopelman T.R. Can empiric broad-spectrum antibiotics for ventilator-associated pneumonia be narrowed based on Gram's stain results of bronchoalveolar lavage fluid?. Am J Surg 2006, 192:812-816.
10. Momez O., Karim A., Mazoit J.X., et al. Gram staining of protected pulmonary specimens in the early diagnosis of ventilator-associated pneumonia. Br J Anesth 2000, 85:735-739.
11. Davis K.A., Eckert M.J., Reed R.L., et al. Ventilator-associated pneumonia in injured patients: do you trust your Gram's stain?. J Trauma 2005, 58:462-466.
12. Aygun G., Yasar H., Yilmaz M., et al. The value of Gram staining of catheter segments for rapid detection of peripheral venous catheter infections. Diagn Microbiol Infect Dis 2006, 54:165-167.
13. ivillage Pregnancy and Parenting, Breastfeeding: Thrash and GentianViolet, January 1, 1999. Available at www.ivillage.com/breastfeeding-thrash-and-gentain-violet/6-n-137337. Accessed September 1, 2011. http://www.ivillage.com/breastfeeding-thrash-and-gentain-violet/6-n-137337.
14. Amir L, Hoover K, Mulford C. Candidiasis and breastfeeding. La Leche League's Lactation Consultant Series. April 2006. Available at www.llli.org/FAQ/thrush.html. Cited June 6, 2009. http://www.llli.org/FAQ/thrush.html.
15. Brown J. Director of marketing, VistaPharm [interview with Karen J. Farid], June 15, 2008.
16. Summary table of antimicrobials for cord care. Care of the umbilical cord/annex. Reproductive Health Publications. 1998. Available at www.who.int/reproductive-health/publications/MSM_98_4_annex. Cited December 27, 2006. http://www.who.int/reproductive-health/publications/MSM_98_4_annex.
17. Bennett J., Macia J., Banoagha S., et al. Protective effects of topical antimicrobials against neonatal tetanus. Int J Epidemiol 1997, 26:897-903.
18. Parashar U.D., Bennet J.V., Boring J.R., et al. Topical antimicrobials applied to the umbilical cord stump: a new intervention against neonatal tetanus. Int J Epidemiol 1998, 27:904-908.
19. Lawrence C. Effect of two different methods of umbilical care on its separation time. Midwives Chronicle Nurs Notes 1982, 95:204-205.
20. Farid K., Farid M., Andrews C. Total contact casting as a part of an adaptive care approach: a case study. Ostomy Wound Manage 2008, 54:50-65.
21. Pupp G.R., Savage D.T., Hillmann M.B. What are the best modalities for Charcot's foot?. Podiatry Today 2002, 15:30-36.
22. Kayama C., Goto Y., Shimoya S., et al. Effects of gentian violet on refractory discharging ears infected with methicillin-resistant Staphylococcus aureus. J Otolaryngol 2006, 35:384-386.
23. Okano M., Noguchi S., Tabata K., et al. Topical gentian violet for cutaneous infection and nasal carriage with MRSA. Int J Dermatol 2000, 39:942-944.
24. Saji M., Taguchi S., Uchiyama K., et al. Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J Hosp Infect 1995, 31:225-228.
25. Bjornberg A., Mobacken H. Necrotic skin lesions caused by 1% gentian violet and brilliant green. Acta Dermatovenereologia 1972, 52:55-60.
26. Davis S.G., Mertz P.M., Eaglstein W.H. Second-degree burn healing: the effect of occlusive dressings and a cream. J Surg Res 1990, 48:245-248.
27. Copley J.B. Prevention of peritoneal dialysis catheter-related infections. Am J Kidney Dis 1987, 10:401-407.
28. Moysés-Neto M., Cherubini A., Batista M.E., et al. Foreign body granuloma at the exit site in patients on CAPD: use of 1% gentian violet as topical treatment. Perit Dial Int 1997, 17:509-511.
29. Runds C.R. Non-conventional topical therapies for wound care. Ostomy Wound Manage 1996, 42:18-26.
30. Rosenkrantz H.S., Carr H.S. Possible hazard in use of gentian violet. BMJ 1971, 3:702-703.
31. Durrani A.J., Miller R.J., Davies M. Basal cell carcinoma arising in a laparoscopic port site scar at the umbilicus. Plastic Reconstr Surg 2005, 116:348-350.
32. Roos J., Hill R.B. Primary umbilical adenocarcinoma: a case report and review of the literature. Arch Pathol 1975, 99:327-329.
33. Colonna M.R., Giovannini U.M., Sturniolo G., et al. The umbilicus: a rare site for melanoma. Clinical consideration in two cases. Scan J Plastic Reconstr Surg Hand Surg 1999, 33:449-452.
34. Lee B.T., Lefor A.T., Didolkar M.S. Squamous cell carcinoma of the umbilicus associated with acquired immune deficiency syndrome. J Surg Oncol 1991, 47:67-69.
35. Norrby K., Mobacken H. Effect of triphenylmethane dyes (brilliant green, crystal violet, methyl violet) on proliferation in human normal fibroblast-like and established epithelial-like cell lines. Acta Dermatovenereol 1972, 52:476-483.
36. Gentian violet: top uses. Harvard Health Publications. Available at www.healthsquare.com/drugs/76435.htm. Cited October 24, 2010. http://www.healthsquare.com/drugs/76435.htm.
37. Larjave H., Koivisto L., Hakkinen L. Keratinocyte interactions with fibronectin during wound healing. Cell invasion [electronic book]. Vol. 33 2002, 3. Medical Intelligence Unit; Landes Bioscience, Georgetown and Austin. J. Heino, V.M. Kahari (Eds.).
38. Aturaliya S., Lukasewycz A. Experimental forensic and bioanthropological aspects of soft tissue taphonomy: I. Factors influencing post-mortem tissue desiccation rate. J Forensic Sci 1999, 44:893-896.
39. Reddy M., Gill S.S., Kaldar S.R., et al. Treatment of pressure ulcers: a systemic review. JAMA 2009, 300:2647-2662.
40. Takahashi P.Y., Kiemele L.J., Chandra A., et al. A retrospective cohort study of factors that affect healing in long-term care residents with chronic wounds. Ostomy Wound Manage 2009, 55:32-37.
41. Stekelenburg A., Oomens C.W.J., Strijkers G.J., et al. Compression-induced deep tissue injury examined with magnetic resonance imaging and histology. J Appl Physiol 2006, 100:1946-1954.
42. Gefen A., Gefen N., Linder-Ganz E., et al. In vivo muscle stiffening under bone compression promotes deep pressure sores. J Biomech Engineer 2005, 127:512-524.
43. Gefen A. Deep tissue injury from a bioengineering point of view. Ostomy Wound Manage 2009, 55:26-36.